P0337PROTEOME CHANGES IN TUBULOINTERSTITIAL TISSUE OF PROGRESSIVE VS NON-PROGRESSIVE IGAN

Abstract Background and Aims IgA nephropathy (IgAN), a common glomerulonephritis worldwide, is associated with a significant risk of progression to end-stage renal failure. In the Oxford classification, tubular atrophy is an established important risk factor for the risk of progression but few studi...

Full description

Saved in:
Bibliographic Details
Published in:Nephrology, dialysis, transplantation dialysis, transplantation, 2020-06, Vol.35 (Supplement_3)
Main Authors: Paunas, Flavia Teodora, Finne, Kenneth, Leh, Sabine, Marti, Hans-Peter, Vikse, Bjørn Egil
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue Supplement_3
container_start_page
container_title Nephrology, dialysis, transplantation
container_volume 35
creator Paunas, Flavia Teodora
Finne, Kenneth
Leh, Sabine
Marti, Hans-Peter
Vikse, Bjørn Egil
description Abstract Background and Aims IgA nephropathy (IgAN), a common glomerulonephritis worldwide, is associated with a significant risk of progression to end-stage renal failure. In the Oxford classification, tubular atrophy is an established important risk factor for the risk of progression but few studies have investigated possible tubulointerstitial markers and the mechanisms of progression in IgAN. The present study investigated changes in the tubulointerstitial proteome from patients with IgAN. Method Based on data from the Norwegian Kidney Biopsy Registry and the Norwegian Renal Registry, two groups were included: IgAN patients with (n=9) or without (n=16) progression to ESRD during 10 years. Tubulointerstitial tissue without discernible interstitial expansion or pronounced tubular alterations were microdissected, proteome was analysed using mass spectrometry and protein abundances were compared between groups. Results: Proteomic analyses quantified 2562 proteins with 2 or more unique peptides . Of these, 201 proteins had significant different abundance between progressive and non-progressive IgAN patients, 96 were more abundant and 105 less abundant. Periostin was the protein with the highest fold change between progressive and non progressive IgAN (fc 9.59, p
doi_str_mv 10.1093/ndt/gfaa144.P0337
format article
fullrecord <record><control><sourceid>oup_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1093_ndt_gfaa144_P0337</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/ndt/gfaa144.P0337</oup_id><sourcerecordid>10.1093/ndt/gfaa144.P0337</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1227-c2bbce1d491de21b580466122a27e96ae0bdda69c0535ce50806597450cec2b13</originalsourceid><addsrcrecordid>eNqNkNFOgzAUhhujiTh9AO_6ALKdFgr0EpeONUFYaFniFSmlGI26BfRiby9uu_DSq5P85_tOcn6E7gnMCfBg8dl9LV56Y0gYzjcQBPEF8kgYgU-DhF0ib2KIDwz4NboZxzcA4DSOPfR8hDdVqUX5JPBynRaZUFgWWNePdV7KQotKaallmmMtlaoFLld4ErJKKCW3Am8VLsrC_xvJLC1u0VVv3kd3d54zVK-EXq79vMzkMs19SyiNfUvb1jrShZx0jpKWJRBG0bQyNHY8Mg7arjMRt8ACZh2DBCLG45CBdZNLghkip7t22I3j4PpmP7x-mOHQEGh-u2mmbppzN83x3cl5ODm77_0_8B8zcWAZ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>P0337PROTEOME CHANGES IN TUBULOINTERSTITIAL TISSUE OF PROGRESSIVE VS NON-PROGRESSIVE IGAN</title><source>Oxford Journals Online</source><creator>Paunas, Flavia Teodora ; Finne, Kenneth ; Leh, Sabine ; Marti, Hans-Peter ; Vikse, Bjørn Egil</creator><creatorcontrib>Paunas, Flavia Teodora ; Finne, Kenneth ; Leh, Sabine ; Marti, Hans-Peter ; Vikse, Bjørn Egil</creatorcontrib><description>Abstract Background and Aims IgA nephropathy (IgAN), a common glomerulonephritis worldwide, is associated with a significant risk of progression to end-stage renal failure. In the Oxford classification, tubular atrophy is an established important risk factor for the risk of progression but few studies have investigated possible tubulointerstitial markers and the mechanisms of progression in IgAN. The present study investigated changes in the tubulointerstitial proteome from patients with IgAN. Method Based on data from the Norwegian Kidney Biopsy Registry and the Norwegian Renal Registry, two groups were included: IgAN patients with (n=9) or without (n=16) progression to ESRD during 10 years. Tubulointerstitial tissue without discernible interstitial expansion or pronounced tubular alterations were microdissected, proteome was analysed using mass spectrometry and protein abundances were compared between groups. Results: Proteomic analyses quantified 2562 proteins with 2 or more unique peptides . Of these, 201 proteins had significant different abundance between progressive and non-progressive IgAN patients, 96 were more abundant and 105 less abundant. Periostin was the protein with the highest fold change between progressive and non progressive IgAN (fc 9.59, p&lt;0.05). Proteins related to inflammation were more abundant and proteins involved in the aerobic energy metabolism and energy demanding ion channels were significantly less abundant in progressive vs non-progressive patients. Conclusion Our study describes extensive proteome changes of tubulo-interstitial tissue in patients with progressive IgAN and indicates several proteins and pathways that are important in the progression of the disease.</description><identifier>ISSN: 0931-0509</identifier><identifier>EISSN: 1460-2385</identifier><identifier>DOI: 10.1093/ndt/gfaa144.P0337</identifier><language>eng</language><publisher>Oxford University Press</publisher><ispartof>Nephrology, dialysis, transplantation, 2020-06, Vol.35 (Supplement_3)</ispartof><rights>The Author(s) 2020. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Paunas, Flavia Teodora</creatorcontrib><creatorcontrib>Finne, Kenneth</creatorcontrib><creatorcontrib>Leh, Sabine</creatorcontrib><creatorcontrib>Marti, Hans-Peter</creatorcontrib><creatorcontrib>Vikse, Bjørn Egil</creatorcontrib><title>P0337PROTEOME CHANGES IN TUBULOINTERSTITIAL TISSUE OF PROGRESSIVE VS NON-PROGRESSIVE IGAN</title><title>Nephrology, dialysis, transplantation</title><description>Abstract Background and Aims IgA nephropathy (IgAN), a common glomerulonephritis worldwide, is associated with a significant risk of progression to end-stage renal failure. In the Oxford classification, tubular atrophy is an established important risk factor for the risk of progression but few studies have investigated possible tubulointerstitial markers and the mechanisms of progression in IgAN. The present study investigated changes in the tubulointerstitial proteome from patients with IgAN. Method Based on data from the Norwegian Kidney Biopsy Registry and the Norwegian Renal Registry, two groups were included: IgAN patients with (n=9) or without (n=16) progression to ESRD during 10 years. Tubulointerstitial tissue without discernible interstitial expansion or pronounced tubular alterations were microdissected, proteome was analysed using mass spectrometry and protein abundances were compared between groups. Results: Proteomic analyses quantified 2562 proteins with 2 or more unique peptides . Of these, 201 proteins had significant different abundance between progressive and non-progressive IgAN patients, 96 were more abundant and 105 less abundant. Periostin was the protein with the highest fold change between progressive and non progressive IgAN (fc 9.59, p&lt;0.05). Proteins related to inflammation were more abundant and proteins involved in the aerobic energy metabolism and energy demanding ion channels were significantly less abundant in progressive vs non-progressive patients. Conclusion Our study describes extensive proteome changes of tubulo-interstitial tissue in patients with progressive IgAN and indicates several proteins and pathways that are important in the progression of the disease.</description><issn>0931-0509</issn><issn>1460-2385</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNqNkNFOgzAUhhujiTh9AO_6ALKdFgr0EpeONUFYaFniFSmlGI26BfRiby9uu_DSq5P85_tOcn6E7gnMCfBg8dl9LV56Y0gYzjcQBPEF8kgYgU-DhF0ib2KIDwz4NboZxzcA4DSOPfR8hDdVqUX5JPBynRaZUFgWWNePdV7KQotKaallmmMtlaoFLld4ErJKKCW3Am8VLsrC_xvJLC1u0VVv3kd3d54zVK-EXq79vMzkMs19SyiNfUvb1jrShZx0jpKWJRBG0bQyNHY8Mg7arjMRt8ACZh2DBCLG45CBdZNLghkip7t22I3j4PpmP7x-mOHQEGh-u2mmbppzN83x3cl5ODm77_0_8B8zcWAZ</recordid><startdate>20200601</startdate><enddate>20200601</enddate><creator>Paunas, Flavia Teodora</creator><creator>Finne, Kenneth</creator><creator>Leh, Sabine</creator><creator>Marti, Hans-Peter</creator><creator>Vikse, Bjørn Egil</creator><general>Oxford University Press</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20200601</creationdate><title>P0337PROTEOME CHANGES IN TUBULOINTERSTITIAL TISSUE OF PROGRESSIVE VS NON-PROGRESSIVE IGAN</title><author>Paunas, Flavia Teodora ; Finne, Kenneth ; Leh, Sabine ; Marti, Hans-Peter ; Vikse, Bjørn Egil</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1227-c2bbce1d491de21b580466122a27e96ae0bdda69c0535ce50806597450cec2b13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Paunas, Flavia Teodora</creatorcontrib><creatorcontrib>Finne, Kenneth</creatorcontrib><creatorcontrib>Leh, Sabine</creatorcontrib><creatorcontrib>Marti, Hans-Peter</creatorcontrib><creatorcontrib>Vikse, Bjørn Egil</creatorcontrib><collection>CrossRef</collection><jtitle>Nephrology, dialysis, transplantation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Paunas, Flavia Teodora</au><au>Finne, Kenneth</au><au>Leh, Sabine</au><au>Marti, Hans-Peter</au><au>Vikse, Bjørn Egil</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>P0337PROTEOME CHANGES IN TUBULOINTERSTITIAL TISSUE OF PROGRESSIVE VS NON-PROGRESSIVE IGAN</atitle><jtitle>Nephrology, dialysis, transplantation</jtitle><date>2020-06-01</date><risdate>2020</risdate><volume>35</volume><issue>Supplement_3</issue><issn>0931-0509</issn><eissn>1460-2385</eissn><abstract>Abstract Background and Aims IgA nephropathy (IgAN), a common glomerulonephritis worldwide, is associated with a significant risk of progression to end-stage renal failure. In the Oxford classification, tubular atrophy is an established important risk factor for the risk of progression but few studies have investigated possible tubulointerstitial markers and the mechanisms of progression in IgAN. The present study investigated changes in the tubulointerstitial proteome from patients with IgAN. Method Based on data from the Norwegian Kidney Biopsy Registry and the Norwegian Renal Registry, two groups were included: IgAN patients with (n=9) or without (n=16) progression to ESRD during 10 years. Tubulointerstitial tissue without discernible interstitial expansion or pronounced tubular alterations were microdissected, proteome was analysed using mass spectrometry and protein abundances were compared between groups. Results: Proteomic analyses quantified 2562 proteins with 2 or more unique peptides . Of these, 201 proteins had significant different abundance between progressive and non-progressive IgAN patients, 96 were more abundant and 105 less abundant. Periostin was the protein with the highest fold change between progressive and non progressive IgAN (fc 9.59, p&lt;0.05). Proteins related to inflammation were more abundant and proteins involved in the aerobic energy metabolism and energy demanding ion channels were significantly less abundant in progressive vs non-progressive patients. Conclusion Our study describes extensive proteome changes of tubulo-interstitial tissue in patients with progressive IgAN and indicates several proteins and pathways that are important in the progression of the disease.</abstract><pub>Oxford University Press</pub><doi>10.1093/ndt/gfaa144.P0337</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0931-0509
ispartof Nephrology, dialysis, transplantation, 2020-06, Vol.35 (Supplement_3)
issn 0931-0509
1460-2385
language eng
recordid cdi_crossref_primary_10_1093_ndt_gfaa144_P0337
source Oxford Journals Online
title P0337PROTEOME CHANGES IN TUBULOINTERSTITIAL TISSUE OF PROGRESSIVE VS NON-PROGRESSIVE IGAN
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T18%3A52%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-oup_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=P0337PROTEOME%20CHANGES%20IN%20TUBULOINTERSTITIAL%20TISSUE%20OF%20PROGRESSIVE%20VS%20NON-PROGRESSIVE%20IGAN&rft.jtitle=Nephrology,%20dialysis,%20transplantation&rft.au=Paunas,%20Flavia%20Teodora&rft.date=2020-06-01&rft.volume=35&rft.issue=Supplement_3&rft.issn=0931-0509&rft.eissn=1460-2385&rft_id=info:doi/10.1093/ndt/gfaa144.P0337&rft_dat=%3Coup_cross%3E10.1093/ndt/gfaa144.P0337%3C/oup_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c1227-c2bbce1d491de21b580466122a27e96ae0bdda69c0535ce50806597450cec2b13%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rft_oup_id=10.1093/ndt/gfaa144.P0337&rfr_iscdi=true